PHARMACY

Tris Pharma launches its Tussionex generic

BY David Salazar

MONMOUTH JUNCTION, N.J. — Specialty pharmaceutical company Tris Pharma on Thursday announced that it had launched its generic version of Tussionex (hydrocodone polistirex and chlorpheniramine) extended-release suspension. 
 
The drug is indicated to treat cough and upper respiratory symptoms of allergies and colds, and will be available in 115- and 473-ml bottles.
 
Tris’ suspension uses its LiquiXR technology, which uses an aqueous base coating system to avoid toxic organic solvents. The generic will be marketed and distributed by the company’s generic business following the expiration of a distribution agreement with Par Pharmaceuticals, who had the rights to it starting in 2010. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

DSN’s Friday Pharmacy Phunny

BY DSN STAFF

The start of October is also the start of American Pharmacists Month, and to celebrate, Drug Store News is launching its Friday Pharmacy Phunny series. Every Friday in October, DSN A.M. will feature a new cartoon aimed at pharmacists and their funny bones. Check out our first installment above, and check back next week for another. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

NACDS concerned with TRICARE provisions in NDAA

BY David Salazar

ARLINGTON, Va. — Earlier this week, Congress released its Conference Report on the 2016 National Defense Authorization Act, which authorizes spending for the U.S. Dept. of Defense, and the National Association of Chain Drug Stores president Steve Anderson has concerns about the bill’s provisions regarding TRICARE.

According to Anderson, the bill contains language that limits pharmacy access and choice for TRICARE beneficiaries — a move that contradicts the DoD’s Military Compensation and Retirement Modernization Commission and lawmaker recommendations. In particular, there are concerns about the bill’s language calling for annual copay revisions starting in 2016. Additionally, Anderson notes the absence of a pilot program that would benefit TRICARE patients.

“We have remained highly engaged in efforts to preserve pharmacy access and choice for TRICARE patients over the years, including consistent advocacy efforts with lawmakers,” Anderson said. “Key to that effort is testing the concept of making available to retail pharmacies the same medication acquisition cost rates enjoyed by mail order and military treatment facilities. The conference agreement omits the pilot program, which would have explored this important concept. We remain committed to seeking the pilot for this program so that we can guarantee that TRICARE beneficiaries get the access to quality care they not only need but deserve.”

Anderson said that the importance of the pilot program and allowing more choice and access for TRICARE patients is about ensuring they have appropriate care.

“Local retail pharmacies provide convenience and value for patients, and it’s unclear why policies are not matching up with opportunities for TRICARE patients to benefit from the services of their local, trusted pharmacists,” he said. “Threatening beneficiary access to prescription medications and their preferred healthcare provider will only increase the use of more costly medical interventions, such as physician and emergency room visits and hospitalizations.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?